Kamada (KMDA) Non-Current Deffered Revenue (2016 - 2021)
Kamada (KMDA) reported Non-Current Deffered Revenue of $15000.0 for Q4 2021, down 99.26% on a YoY basis from $2.0 million in Q4 2020, and down 99.26% quarter-over-quarter from $2.0 million in Q4 2020.
Kamada (KMDA) Non-Current Deffered Revenue (2016 - 2021) Analysis & Trends
Kamada has reported Non-Current Deffered Revenue for 6 years, with the latest figure at $15000.0 in Q4 2021.
- For the quarter ending Q4 2021, Non-Current Deffered Revenue fell 99.26% year-over-year to $15000.0; the trailing twelve-month figure through Dec 2021 stood at $15000.0 (down 99.26% YoY), and the FY2021 full-year result was $15000.0, down 99.26% from the prior year.
- Non-Current Deffered Revenue for Q4 2021 stood at $15000.0, down from $2.0 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $2.0 million in Q4 2020, with the low at $15000.0 in Q4 2021.
- Historically, Non-Current Deffered Revenue has averaged $729400.0 across 5 years, with a median of $668000.0 in 2018.
- Annual changes were most pronounced in 2020 — Non-Current Deffered Revenue jumped 772.84% — and 2021, when it slumped 99.26%.
- Kamada's Non-Current Deffered Revenue stood at $707000.0 in 2017, then fell by 5.52% to $668000.0 in 2018, then sank by 65.27% to $232000.0 in 2019, then jumped by 772.84% to $2.0 million in 2020, then tumbled by 99.26% to $15000.0 in 2021.
- The last three Non-Current Deffered Revenue figures came in at $15000.0 (Q4 2021), $2.0 million (Q4 2020), and $232000.0 (Q4 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Kamada | 521.50 | -73.15 Mn | 19.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 15,000.00 |
| Dec 31, 2020 | 2.03 Mn |
| Dec 31, 2019 | 232,000.00 |
| Dec 31, 2018 | 668,000.00 |
| Dec 31, 2017 | 707,000.00 |
| Dec 31, 2016 | 3.66 Mn |